Phase 3 SOPHIA Study
Scott Koenig discusses the Phase 3 SOPHIA study.<br /><br />About MacroGenics, Inc.<br /><br />MacroGenics is a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal ant...
Author: Annual-Meeting
Added: 06/07/2019
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Cancer & Oncology | Study